NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 937 filers reported holding NOVARTIS A G in Q2 2015. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,420 | -12.6% | 387 | -13.4% | 0.00% | 0.0% |
| Q2 2023 | $45,107 | +13.8% | 447 | +3.7% | 0.00% | 0.0% |
| Q1 2023 | $39,649 | -5.0% | 431 | -6.3% | 0.00% | 0.0% |
| Q4 2022 | $41,731 | -89.1% | 460 | -89.4% | 0.00% | -90.0% |
| Q1 2022 | $382,000 | +28.6% | 4,356 | +28.1% | 0.02% | +33.3% |
| Q4 2021 | $297,000 | +15.6% | 3,400 | +7.8% | 0.02% | 0.0% |
| Q3 2021 | $257,000 | -92.5% | 3,154 | -91.5% | 0.02% | -97.5% |
| Q3 2015 | $3,410,000 | -9.4% | 37,093 | -3.1% | 0.60% | +20.0% |
| Q2 2015 | $3,763,000 | -8.3% | 38,267 | -8.1% | 0.50% | -8.3% |
| Q1 2015 | $4,105,000 | +3.8% | 41,628 | -2.5% | 0.54% | -0.5% |
| Q4 2014 | $3,955,000 | -5.6% | 42,687 | -4.1% | 0.55% | -6.5% |
| Q3 2014 | $4,189,000 | +4.2% | 44,500 | +0.2% | 0.59% | +1.0% |
| Q2 2014 | $4,020,000 | +7.6% | 44,405 | +1.1% | 0.58% | -2.2% |
| Q1 2014 | $3,735,000 | +9.4% | 43,930 | +3.4% | 0.59% | -9.7% |
| Q4 2013 | $3,414,000 | +7.1% | 42,470 | +2.2% | 0.66% | -1.9% |
| Q3 2013 | $3,188,000 | – | 41,565 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |